In Pain relief Enzogrip Tablet is used for relief of pain, inflammation, and swelling in conditions that may occur due to trauma, surgery or everyday life. It may also be used to provide relief in degenerative and inflammatory conditions that affect muscles and joints such as rheumatoid arthritis and osteoarthritis. It provides effective resolution of inflammatory symptoms and promotes speedy recovery due to its anti-inflammatory and antioxidant properties. Take it as it is prescribed to get the most benefit. This will help you to go about your daily activities more easily and have a better, more active, quality of life. In Swelling Enzogrip Tablet is a combination of various enzymes that blocks certain chemicals that causes swelling. It also contains an antioxidant that protects the body from damage and further reduces swelling. This eases you from discomfort and helps you carry out your daily activities easily.
It is not known whether it is safe to consume alcohol with Enzogrip Tablet. Please consult your doctor.
Information regarding the use of Enzogrip Tablet during pregnancy is not available. Please consult your doctor.
Information regarding the use of Enzogrip Tablet during breastfeeding is not available. Please consult your doctor.
It is not known whether Enzogrip Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
There is limited information available on the use of Enzogrip Tablet in patients with kidney disease. Please consult your doctor.
There is limited information available on the use of Enzogrip Tablet in patients with liver disease. Please consult your doctor.
If you miss a dose of Enzogrip Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More